• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Novel theraputic approach for maligannt glioma using endothelial progenitor cell.

Research Project

Project/Area Number 23659689
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Cerebral neurosurgery
Research InstitutionOita University of Nursing and Health Sciences (2012-2013)
International University of Health and Welfare (2011)

Principal Investigator

HIROMICHI NAKABAYASHI  大分県立看護科学大学, 看護学部, 教授 (70346716)

Co-Investigator(Kenkyū-buntansha) 天野 託  国際医療福祉大学, 薬学部, 教授 (10294547)
中谷 善彦  国際医療福祉大学, 薬学部, 助教 (40582169)
Co-Investigator(Renkei-kenkyūsha) 中谷 善彦  国際医療福祉大学, 薬学部, 助教 (40582169)
Project Period (FY) 2011 – 2013
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2013: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Keywords悪性グリオーマ / 血管内皮前駆細胞 / TRAIL / avidin-biotin system / biotin-avidin / biotin-avidin system
Research Abstract

Due to their unique property to cross the blood-brain barier and to migrate to pathological lesions, endothelial progenitor cell (EPC) is expected as a new therapeutic tool for malignant glioma. EPCs were genetically modified by using tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in the first aproach. On the other hand, the surface of EPC was modified by using avidin-niotin system and TRAIL protein. Modified EPCs were proved to be effective to induce the apoptosis of malignant glioma cells.

Report

(4 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Research-status Report
  • 2011 Research-status Report
  • Research Products

    (4 results)

All 2013 Other

All Presentation (4 results)

  • [Presentation] A novel fluorinated stilbene exerts antitumor activity in glioblastoma cells.2013

    • Author(s)
      Nakabayashi H, Yawata T
    • Organizer
      2013 European congress of pathology
    • Place of Presentation
      Lisbon, PORTUGAL
    • Related Report
      2013 Annual Research Report
  • [Presentation] Antitumour effect of Apigenin against glioblastoma cell lines.2013

    • Author(s)
      Nakabayashi H, Yawata T
    • Organizer
      2013 European Cancer Congress
    • Place of Presentation
      Amsterdam, Netherlands
    • Related Report
      2013 Annual Research Report
  • [Presentation] A novel fluorinated stilbene exerts antitumor activity in glioblastoma cells

    • Author(s)
      Nakabayashi H, et al.
    • Organizer
      2013 European congress of pathology
    • Related Report
      2013 Final Research Report
  • [Presentation] Antitumour effect of Apigenin against glio-blastoma cell lines

    • Author(s)
      Nakabayashi H, et al.
    • Organizer
      2013 European Cancer Congress
    • Related Report
      2013 Final Research Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi